NIPUN MERCHANT is joining the Sylvester Comprehensive Cancer Center as chief surgical officer and director of Surgical Oncology Research Programs.
Joseph McLaughlin, an internationally recognized epidemiologist who made numerous contributions towards increasing understanding of the causes of cancer, died unexpectedly Dec. 10, 2014.
FDA approved Opdivo (nivolumab) injection for the treatment of patients with unresectable or metastatic melanoma and disease progression following Yervoy (ipilimumab) and, if BRAF V600 mutation positive, a BRAF inhibitor.
SHARMILA MAKHIJA was named professor and chair of the Department of Obstetrics & Gynecology and Women's Health at Albert Einstein College of Medicine and Montefiore Health System, effective April 1.
DONALD “SKIP” TRUMP was named the first CEO and executive director of the newly created Inova Cancer Care and Research Institute, part of the Inova Health System.
New Perspective on Nevins and Potti
Nevins Acknowledges Gravity of the Situation
Repeating the Third Year?
Duke University would have avoided embarrassment, a misconduct investigation and a lawsuit, had its top administrators paid closer attention to a thoughtful report by a medical student who saw problems in the lab of the disgraced scientist Anil Potti.
Polaris Group's lead product candidate, ADI-PEG 20 (pegylated arginine deiminase), received orphan drug designations for the treatment of malignant pleural mesothelioma in the U.S. and the European Union.
